-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral TherapyU.S. Food and Drug Administration • Press Release
Labeling Update for Lexiva (Fosamprenavir)
December 21, 2007
The Lexiva (fosamprenavir) label was recently updated to include new drug-drug interaction information regarding phenytoin (an anticonvulsant) and paroxetine (an antidepressant).
Details of the newly added information are contained in the attached PDF file.
The complete revised label is available here.
This article was provided by U.S. Food and Drug Administration.
  |
  |